During review of a revisit note, the clinician documented that the patient ambulated 180 feet continuously. Based on the patient’s functional status, this distance was not clinically consistent with the patient’s tolerance. The more accurate documentation was 45 feet × 4 trials with rest breaks. This discrepancy was identified during QA review and clarified with the clinician.
Overstating ambulation ability may misrepresent the patient’s endurance, activity tolerance, and functional status, potentially leading to unrealistic goals, inappropriate treatment progression, and inaccurate assessment of fall risk.
Recording cumulative ambulation distance as one continuous effort may be considered misleading if rest breaks are not clearly documented.
Documenting 180 feet as a single ambulation attempt, when the patient actually completed 45 feet × 4 with rest periods, may overstate functional performance and reduce the credibility of the therapy note. QA review identified the issue, and the clinician was instructed to document each ambulation segment and associated rest breaks accurately.
Identify documentation gaps, reduce risk, and protect your revenue.
Let's discuss your challenges and explore how we can help your agency thrive.